COMPANY

iVEAcare

Profile checked Oct 10, 2026

Keywords: Drug Resistant Epilepsy iVEAcare Neuromodulation System

Timeline

Jul 29, 2026 Trial start Not phased (device or behavioral study): Feasibility Study of the iVEAcare Neuromodulation System for the Treatment of Drug-Resistant Epilepsy source ↗

2027-07 (ESTIMATED) · Not phased · Feasibility Study of the iVEAcare Neuromodulation System for the Treatment of Drug-Resistant Epilepsy · NCT07640191

Estimated primary completion per ClinicalTrials.gov. Dates move.

Record	Title	Phase	Status	Start	Primary completion
NCT07640191	Feasibility Study of the iVEAcare Neuromodulation System for the Treatment of Drug-Resistant Epilepsy	Not phased (device or behavioral study)	Recruiting	Jul 29, 2026	2027-07 (estimated)